A detailed history of N Verses Capital, LLC transactions in Delcath Systems, Inc. stock. As of the latest transaction made, N Verses Capital, LLC holds 1,600 shares of DCTH stock, worth $17,696. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,600
Previous 1,500 6.67%
Holding current value
$17,696
Previous $12.6 Million 15.08%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$7.36 - $11.0 $736 - $1,100
100 Added 6.67%
1,600 $14.4 Million
Q2 2024

Jul 31, 2024

BUY
$4.47 - $8.37 $6,705 - $12,554
1,500 New
1,500 $12.6 Million

Others Institutions Holding DCTH

About DELCATH SYSTEMS, INC.


  • Ticker DCTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 8,597,680
  • Market Cap $95.1M
  • Description
  • Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...
More about DCTH
Track This Portfolio

Track N Verses Capital, LLC Portfolio

Follow N Verses Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of N Verses Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on N Verses Capital, LLC with notifications on news.